Cite Filings / VRDN / 0001104659-22-092995

Feed Companies Filings Check

Sign in

SC 13D/A

Beneficial Ownership Report

Viridian Therapeutics, Inc.\DE Filed 2022-08-19 Acc 0001104659-22-092995

Documents 1

SC 13D/A Beneficial Ownership Report , tm2224207d1_sc13da.htm

Around this filing

2023-06-14 SC 13D/A Beneficial Ownership Report
2022-08-19 8-K Material agreement
2022-08-19 SC 13D/A Beneficial Ownership Report
2022-08-19 4 Director bought 425,531 shares at $23.50 ($9,999,979)
2022-08-18 424B5 Prospectus
2022-08-17 424B3 Prospectus
2021-09-23 SC 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2224207d1_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…